Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006)
Resource Type
Article
Authors
Schachter, Jacob ; Ribas, Antoni ; Long, Georgina V ; Arance, Ana ; Grob, Jean-Jacques ; Mortier, Laurent ; Daud, Adil ; Carlino, Matteo S ; McNeil, Catriona ; Lotem, Michal ; Larkin, James ; Lorigan, Paul ; Neyns, Bart ; Blank, Christian ; Petrella, Teresa M ; Hamid, Omid ; Zhou, Honghong ; Ebbinghaus, Scot ; Ibrahim, Nageatte ; Robert, Caroline
Source
In The Lancet 21-27 October 2017 390(10105):1853-1862
Subject
Primary Research Articles
Language
ISSN
0140-6736